These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22581074)

  • 21. Prospective cohort study of impulse control disorders in Parkinson's disease.
    Bastiaens J; Dorfman BJ; Christos PJ; Nirenberg MJ
    Mov Disord; 2013 Mar; 28(3):327-33. PubMed ID: 23283708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex, drugs and Parkinson's disease.
    Ushe M; Perlmutter JS
    Brain; 2013 Feb; 136(Pt 2):371-3. PubMed ID: 23413258
    [No Abstract]   [Full Text] [Related]  

  • 23. The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: A cross-sectional multicenter study.
    Vela L; Martínez Castrillo JC; García Ruiz P; Gasca-Salas C; Macías Macías Y; Pérez Fernández E; Ybot I; Lopez Valdés E; Kurtis MM; Posada Rodriguez IJ; Mata M; Ruiz Huete C; Eimil M; Borrue C; Del Val J; López-Manzanares L; Rojo Sebastian A; Marasescu R
    J Neurol Sci; 2016 Sep; 368():150-4. PubMed ID: 27538621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and psychopathological factors associated with impulse control disorders in Parkinson's disease].
    Sáez-Francàs N; Martí Andrés G; Ramírez N; de Fàbregues O; Álvarez-Sabín J; Casas M; Hernández-Vara J
    Neurologia; 2016 May; 31(4):231-8. PubMed ID: 26096669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impulse control disorders in Parkinson's disease: A systematic review on risk factors and pathophysiology.
    Latella D; Maggio MG; Maresca G; Saporoso AF; Le Cause M; Manuli A; Milardi D; Bramanti P; De Luca R; Calabrò RS
    J Neurol Sci; 2019 Mar; 398():101-106. PubMed ID: 30690412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impulse control disorders in Parkinson's disease.
    Marques A; Durif F; Fernagut PO
    J Neural Transm (Vienna); 2018 Aug; 125(8):1299-1312. PubMed ID: 29511827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of impulse control disorders in Parkinson's disease: a prospective controlled study.
    Wirth T; Goetsch T; Corvol JC; Roze E; Mariani LL; Vidailhet M; Grabli D; Mallet L; Pelissolo A; Rascol O; Brefel-Courbon C; Ory-Magne F; Arbus C; Bekadar S; Krystkowiak P; Marques A; Llorca M; Krack P; Castrioto A; Fraix V; Maltete D; Defebvre L; Kreisler A; Houeto JL; Tranchant C; Meyer N; Anheim M
    J Neurol; 2024 May; 271(5):2412-2422. PubMed ID: 38214756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piribedil and pathological gambling in six parkinsonian patients.
    Micheli FE; Giugni JC; Espinosa ME; Calvo DS; Raina GB
    Arq Neuropsiquiatr; 2015 Feb; 73(2):115-8. PubMed ID: 25742580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist.
    Auyeung M; Tsoi TH; Tang WK; Cheung CM; Lee CN; Li R; Yeung E
    Parkinsonism Relat Disord; 2011 Sep; 17(8):635-7. PubMed ID: 21705258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypersexuality and other impulse control disorders in Parkinson's disease].
    Nelis EA; Berendse HW; van den Heuvel OA
    Ned Tijdschr Geneeskd; 2016; 160():A9359. PubMed ID: 26732226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impulse control disorders in Parkinson's disease: Predominant role of psychological determinants.
    Garlovsky JK; Simpson J; Grünewald RA; Overton PG
    Psychol Health; 2016 Dec; 31(12):1391-1414. PubMed ID: 27473645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of impulse control disorders in Parkinson's disease: Practical considerations and future directions.
    Ramirez-Zamora A; Gee L; Boyd J; Biller J
    Expert Rev Neurother; 2016; 16(4):389-99. PubMed ID: 26923084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of impulse control disorders in Parkinson's disease.
    Zhang S; Dissanayaka NN; Dawson A; O'Sullivan JD; Mosley P; Hall W; Carter A
    Int Psychogeriatr; 2016 Oct; 28(10):1597-614. PubMed ID: 27373317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs.
    Poletti M; Logi C; Lucetti C; Del Dotto P; Baldacci F; Vergallo A; Ulivi M; Del Sarto S; Rossi G; Ceravolo R; Bonuccelli U
    J Clin Psychopharmacol; 2013 Oct; 33(5):691-4. PubMed ID: 23857310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impulse Control Disorders in Parkinson's Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management.
    Carbone F; Djamshidian A
    CNS Drugs; 2024 Jun; 38(6):443-457. PubMed ID: 38613665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impulsive choice and response in dopamine agonist-related impulse control behaviors.
    Voon V; Reynolds B; Brezing C; Gallea C; Skaljic M; Ekanayake V; Fernandez H; Potenza MN; Dolan RJ; Hallett M
    Psychopharmacology (Berl); 2010 Jan; 207(4):645-59. PubMed ID: 19838863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impulse control disorders in Parkinson's: Sleep disorders and nondopaminergic associations.
    Carbunaru S; Eisinger RS; Ramirez-Zamora A; Bassan D; Cervantes-Arriaga A; Rodriguez-Violante M; Martinez-Ramirez D
    Brain Behav; 2018 Mar; 8(3):e00904. PubMed ID: 29541533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
    Seeman P
    Synapse; 2015 Apr; 69(4):183-9. PubMed ID: 25645960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of impulse control disorders in Parkinson's disease.
    Mamikonyan E; Siderowf AD; Duda JE; Potenza MN; Horn S; Stern MB; Weintraub D
    Mov Disord; 2008 Jan; 23(1):75-80. PubMed ID: 17960796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study.
    Jeon N; Bortolato M
    PLoS One; 2020; 15(1):e0227128. PubMed ID: 31910240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.